CYP 3.13% 33.0¢ cynata therapeutics limited

I believe that this is the research paper:"iPSC- and...

  1. 152 Posts.
    lightbulb Created with Sketch. 143
    I believe that this is the research paper:

    "iPSC- and mesenchymoangioblast-derived mesenchymal stem cells provide greater protection against experimental chronic allergic airways disease compared with a clinically used corticosteroid"

    https://faseb.onlinelibrary.wiley.com/doi/epdf/10.1096/fj.201802307R


    Sounds like a worthwhile patent, more effective combination therapy.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
0.010(3.13%)
Mkt cap ! $59.27M
Open High Low Value Volume
31.0¢ 33.0¢ 30.0¢ $36.91K 116.8K

Buyers (Bids)

No. Vol. Price($)
1 3000 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 28248 3
View Market Depth
Last trade - 16.10pm 04/06/2024 (20 minute delay) ?
Last
32.0¢
  Change
0.010 ( 1.59 %)
Open High Low Volume
30.0¢ 32.0¢ 30.0¢ 37199
Last updated 13.23pm 04/06/2024 ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.